Vom Bereuen einer radikalen Krebstherapie

Schwerwiegendere Infektionen rational zu therapieren, ist eine Herausforderung. Wie kann die Dauer von Antibiotika gesteuert und deren Gabe patientenfreundlich gestaltet werden? Wann ist intravenös besser, wann ist eine Oralisierung vertretbar? Prof. Norma Jung fasst die aktuelle ...  Show more

Kriege, Genozide und schwere Repressionen hinterlassen kollektive Traumata, die bis heute Gesellschaft und Individuen beeinflussen. Im Springer Medizin Podcast erläutert Prof. Dr. Dr. Andreas Maercker, wie wir diesen Traumata begegnen und was aus psychotherapeutischer Sicht nötig ...  Show more

An interview with Dr. Rohan Garje from Miami Cancer Institute in Miami, FL, lead author on "Systemic Therapy Update on 177Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Rapid Recommendation." Dr. Garje reviews the new evidence and the latest recommend ...  Show more

Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ...  Show more

You have a patient who underwent local excision of a rectal cancer. Final pathology demonstrates a T2 lesion. What is the rate of local recurrence? Is excision alone sufficient? Should the patient undergo radical resection or should chemoradiation be offered? Tune in to find out! ...  Show more

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoin ...